Jones Day

Antitrust; Competition Law; Banking Law; Finance; Business Restructuring; Reorganization; Capital Markets; Corporate Criminal Investigations; Employee Benefits; Executive Compensation; Energy; Environmental Law; Health Law; Safety; Financial Institutions Litigation; Regulation; Government Regulation; Insurance Recovery; Health Care; Intellectual Property; International Litigation; Arbitration; Issues; Appellate Practice; Labor and Employment; Mergers and Acquisitions; Private Equity; Product Liability; Torts; Real Estate; Securities; Shareholder Litigation; Sec Enforcement; Tax Law; Trial Practice.

Europe's Highest Court Decides on Patent Term Extensions for Fixed-Combination Medicinal Products
Christian B. Fulda,Christian Paul,Niklas Piening,Christiane Schweizer,Martin Weber, December 21, 2011
Several national patent term extension proceedings regarding fixed-combination medicinal products have been stayed in Europe since UK courts have referred two cases to the highest European court—the Court of Justice of the European Union. The Court of Justice has now decided these cases...

Europe's Landmark Decision on Stem Cell Patents, or: The Strict European View on Life
Christian Paul,Niklas Piening,Martin Weber, November 1, 2011
In a landmark decision on October 18, 2011, the highest court of the European Union—the Court of Justice—decided on the patentability of stem-cell-related inventions (case number C-34/10). The dispute arose around the definition of the term "human embryo" in the European...

Recent Developments in FCA Cases: Filings, Motions, and Settlements
Theodore T. Chung,Laura A. Dahl,Christian B. Fulda,Heather M. O'Shea, September 21, 2011
Recent notable FCA cases involving participants in the health care industry include the following:

Return to the Jones Day Firm Overview